Close
Open Nav
2019 Schedule of Events

Sunday, February 10 (BIO Executive Leadership Courses—added fee)

1:00 PM – 5:30 PM 

Improving Negotiations and Decision Making By Applying Game Theory

 

Monday, February 11

6:00 AM – 6:00 PM 

Registration

6:30 AM – 8:00 AM

Continental Breakfast

6:30 AM – 6:00 PM

BIO One-on-One Partnering Desk

7:20 AM – 6:00 PM

Satellite BIO One-on-One Partnering Desk

7:30 AM - 5:30 PM

BIO One-on-One Partnering Hospitality Suite

7:30 AM - 6:00 PM

BIO One-on-One Partnering Meetings

9:00 AM - 11:30 AM

Company Presentations

9:00 AM - 9:55 AM

Reshaping Tumor Microenvironments via Immunotherapies

10:00 AM - 10:55 AM

Fireside Chat: Nancy Thornberry, CEO, Kallyope

11:00 AM - 11:55 AM

Advances in Neuromuscular Disease Treatments

11:45 AM - 1:00 PM

Boxed Lunches Available

12:00 PM - 12:44 PM Fireside Chat: Geoff Meyerson, Managing Partner and Co-Founder, Locust Walk

1:30 PM - 2:25 PM

Navigating Payers’ Expectations for Value-Based Agreements

1:15 PM - 4:15 PM

Company Presentations

2:30 PM - 3:25 PM

Fireside Chat: Jinzi Wu, PhD, Founder, Chairman, and CEO, Ascletis Pharma Inc.

3:30 PM - 4:25 PM Attacking Biological Mechanisms of Aging to Extend Healthspan

4:30 PM - 5:45 PM

Market Outlook - Leveraging Market Corrections for M&A or IPOs

6:00 PM - 7:00 PM

Welcome Reception

 

Tuesday, February 12

6:30 AM - 4:00 PM

Registration

6:30 AM - 8:00 AM

Continental Breakfast

6:30 AM - 5:30 AM

BIO One-on-One Partnering Desk

6:50 AM - 6:00 PM

Satellite BIO One-on-One Partnering Desk

7:00 AM – 5:00 PM

BIO One-on-One Partnering Hospitality Suite

7:00 AM – 5:30 PM

BIO One-on-One Partnering Meetings

9:00 AM – 11:30 AM

Company Presentations

9:00 AM – 9:55 AM

New Treatments for Diabetes and Obesity: Innovations for Chronic Diseases

10:00 AM - 10:55 AM

Fireside Chat: William Slattery, Partner, Deerfield; and Annette Grimaldi, Managin Director & Head of Life Sciences Investment Banking, BMO Captial Markets

11:00 AM - 11:55 AM

Policy Outlook—How Could the Trump Administration’s Drug Reimbursement Proposals Affect Medical Innovation?

11:45 AM – 1:00 PM

Boxed Lunches Available

12:00 PM - 12:55 PM

Fireside Chat: Roger Crystal, MD, Chief Executive Officer, Opiant Pharmaceuticals

1:15 PM – 3:45 PM

Company Presentations

1:00 PM - 1:55 PM

Regulatory Changes to Cross-Border Investments: CFIUS and Biotech Deals

2:00 PM - 2:55 PM

Removing Commercialization Barriers for New Antimicrobial Drugs

3:00 PM - 3:55 PM

Fireside Chat: Dr. Aoife M. Brennan, President and Chief Executive Officer and Chief Medical Officer, Synlogic, Inc.

4:00 PM - 4:55 PM

Are Record Levels of IPOs Still Disrupting M&A Deals?

5:00 PM - 6:00 PM

Closing Reception